miércoles, 7 de octubre de 2026
BuscarExplore
es.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· June 23, 2026

Health Catalyst, Zoom, and Autodesk Shares Are Falling, What You Need To Know

View original at finance.yahoo.com
Health Catalyst, Zoom, and Autodesk Shares Are Falling, What You Need To Know Health Catalyst, Zoom, and Autodesk Shares Are Falling, What You Need To Know What Happened?…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Salesforce is a Rule-of-40 company retiring 10% of its shares through a $25 billion buyback

    60% confidence

  • AI agents will erode the subscription model that underpins traditional enterprise software economics

    60% confidence

  • The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks

    60% confidence

  • Until enterprise software companies prove AI revenue scales faster than it erodes the legacy subscription base, software stocks may remain in the penalty box even on days when chip stocks rally

    60% confidence

  • Salesforce is acquiring m3ter to monetize AI agent actions rather than per-seat subscriptions

    60% confidence

  • Salesforce is a Buy on valuation grounds

    60% confidence

  • The software sell-off has become indiscriminate; the market is pricing AI cannibalization as if it already happened while income statements may be indicating otherwise

    60% confidence

  • AI is compressing demand for traditional IT services

    60% confidence

  • If the largest IT services firm in the world signals AI is eating its billable hours, investors will extend the same logic to software vendors whose products those hours configure

    60% confidence

  • Salesforce carries the largest AI revenue line in the enterprise software category

    60% confidence

Data points we hold from this source

Salesforce · stock price152 USD
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,986
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,986 hechos verificados con la fuente5,362 documentos fuente archivados
Consulta estos datos → isubstrate.com
Health Catalyst, Zoom, and Autodesk Shares Are Falling, What You Need To Know — Source | Via News | es.VIA.NEWS